Latest publications
Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine
Nurminen, A., Jaatinen, S., Taavitsainen, S., Högnäs, G., Lesluyes, T., Ansari-Pour, N., Tolonen, T., Haase, K., Koskenalho, A., Kankainen, M., Jasu, J., Rauhala, H., Kesäniemi, J., Nikupaavola, T., Kujala, P., Rinta-Kiikka, I., Riikonen, J., Kaipia, A., Murtola, T., Tammela, T. L., & 5 others , Oct 2023, In: Genome Medicine. 15, 15 p., 82.Research output: Contribution to journal › Article › Scientific › peer-review
Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases
Sattari, M., Kohvakka, A., Moradi, E., Rauhala, H., Urhonen, H., Isaacs, W. B., Nykter, M., Murtola, T. J., Tammela, T. L. J., Latonen, L., Bova, G. S., Kesseli, J. & Visakorpi, T., 2023, In: Endocrine-Related Cancer. 30, 8, 12 p., e220247 .Research output: Contribution to journal › Article › Scientific › peer-review
Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen
Kukkonen, K., Autio-Kimura, B., Rauhala, H., Kesseli, J., Nykter, M., Latonen, L. & Visakorpi, T., 7 Nov 2022, In: Endocrine-Related Cancer. 29, 12, p. 717-733 17 p.Research output: Contribution to journal › Article › Scientific › peer-review
Search for KPNA7 cargo proteins in human cells reveals MVP and ZNF414 as novel regulators of cancer cell growth
Vuorinen, E. M., Rajala, N. K., Rauhala, H. E., Nurminen, A. T., Hytönen, V. P. & Kallioniemi, A., 2017, In: BIOCHIMICA ET BIOPHYSICA ACTA: MOLECULAR BASIS OF DISEASE. 1863, 1, p. 211-219Research output: Contribution to journal › Article › Scientific › peer-review
Epigenetically altered miR-193b targets cyclin D1 in prostate cancer
Kaukoniemi, K. M., Rauhala, H. E., Scaravilli, M., Latonen, L., Annala, M., Vessella, R. L., Nykter, M., Tammela, T. LJ. & Visakorpi, T., 2015, In: Cancer Medicine. 4, 9, p. 1417-1425Research output: Contribution to journal › Article › Scientific › peer-review
CCND1 is a miR-193b target in prostate cancer
Tuppurainen, K., Rauhala, H., Scaravilli, M., Vessella, R. & Visakorpi, T., 2014, Unknown. Vol. 74. p. 5205 (Cancer Research; vol. 74, no. S19).Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Scientific
KPNA7, a nuclear transport receptor, promotes malignant properties of pancreatic cancer cells in vitro
Laurila, E., Vuorinen, E., Savinainen, K., Rauhala, H. & Kallioniemi, A., 2014, In: Experimental Cell Research. 322, 1, p. 159-167 9 p.Research output: Contribution to journal › Article › Scientific › peer-review
Silencing of the arp2/3 complex disturbs pancreatic cancer cell migration
Rauhala, H. E., Teppo, S., Niemelä, S. & Kallioniemi, A., 2013, In: Anticancer Research. 33, 1, p. 45-52 8 p.Research output: Contribution to journal › Article › Scientific › peer-review
miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer
Rauhala, HE., Jalava, SE., Isotalo, J., Bracken, H., Lehmusvaara, S., Tammela, TL., Oja, H. & Visakorpi, T., 2010, In: International Journal of Cancer. 127, 6, p. 1363-1372Research output: Contribution to journal › Article › Scientific › peer-review
DNA hypermethylation in prostate cancer
Rauhala, H., 2009, Tampere. 126 p. (Acta Universitatis Tamperensis)Research output: Book/Report › Doctoral thesis › Collection of Articles